← All patents

US20240199735A1

Microfibrillar-Associated Protein 5 (MFAP5)-Targeting Monoclonal Antibodies and …

University of Texas System

Abstract

Disclosed are antibody compositions and methods for treatment mammalian cancers. Also disclosed are methods for use of the disclosed MFAP5-specific monoclonal antibodies and antigen-binding-fragments thereof, in the treatment, prophylaxis, and/or the amelioration of one or more symptoms of …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Stephen T.C. Wong
Priority date
July 22, 2019
Filing date
July 22, 2020
Publication date
June 20, 2024
Language
en
Metadata fetched
August 29, 2026 00:32